Mentholated insulin can generally be used in combination with Repaglinide, but it should be used in a scientific and standardized manner under the guidance of a doctor. Mentholated insulin and Repaglinide are not explicitly mentioned in the instruction manual that the two drugs can not be used together, therefore, in line with the indications of the drug, and there are no contraindications, the two drugs can be used in combination. Mentholated insulin is a fast-acting insulin, which can bind to peripheral insulin receptors, increase the uptake and utilization of glucose by peripheral tissues and inhibit the release of hepatic glycogen, so as to play a hypoglycemic effect. It is used for the treatment of type 1 diabetes mellitus, diabetic ketoacidosis, and type 2 diabetes mellitus in which hypoglycemic drugs are ineffective. Hypoglycemic episodes, allergy to this drug is prohibited, after taking the drug may appear panic, sweating, hunger, coma, fainting, nausea, vomiting and other adverse reactions. Repaglinide is a sulfonylurea pro-insulin secretion agent, which can stimulate pancreatic β-cells to rapidly secrete insulin, thus exerting glucose-lowering level, and is suitable for the treatment of type 2 diabetes mellitus.It is contraindicated in type 1 diabetes mellitus, diabetic ketoacidosis, severe hepatic dysfunction, and those who are allergic to the drug, and may have adverse reactions such as dizziness, sweating, panic, headache, and tremor. Pay attention to the use of medication under the guidance of a physician.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
